Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bleomycin + sodium tetradecyl sulfate
- Development stage
- Unknown
- Lead developer
- Nippon Kayaku
- Modality
- Small Molecules
- Administration
- Intralesional Injection, Intravenous Injection (for Individual Components)
01
Overview
This is a combination therapy of two agents—bleomycin and sodium tetradecyl sulfate (marketed as Fibrovein)—used primarily for sclerotherapy in the treatment of vascular malformations and varicose veins. Bleomycin is a cytotoxic glycopeptide antibiotic with antineoplastic activity, acting mainly by inducing DNA strand breaks through free radical formation. Sodium tetradecyl sulfate is an anionic surfactant that acts as a sclerosant, causing endothelial damage and subsequent fibrosis when injected into veins or vascular lesions. The combination may be used intralesionally to enhance sclerosing efficacy in certain vascular anomalies[3][6][8].
- Other names
- bleomycin + Fibroveinbleomycin + sodium tetradecyl sulfate
02
Targets
DNA
Beyond the preview
Go deeper on bleomycin + sodium tetradecyl sulfate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bleomycin + sodium tetradecyl sulfate.